{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"22"}]}],"title":"Bone pain"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"20"}]}],"title":"Thrombocytopenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"18"}]}],"title":"Anemia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"12"}]}],"title":"Alkaline phosphatase increased"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"title":"Nausea and/or vomiting"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"10"}]}],"title":"Leukocytosis"}],"denoms":[{"counts":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"description":"-Adverse events will be assessed using CTCAE version 4.0","groups":[{"description":"XM02 Filgrastim (Granix) 10 mg/kg Days 1 through 4 (Days 5 through 8 may be required if target collection goal has not be met)\n\nPlerixafor 0.24 mg/kg Day 4 (Days 5 through 7 may be required if target collection goal has not be met)\n\nApheresis on Day 5 (may need to be done on Days 6-8 if target collection goal has not been met)","id":"OG000","title":"XM02 Filgrastim (Granix) and Plerixafor"},{"description":"Filgrastim (Neupogen) 10 mg/kg Days 1 through 4 (Days 5 through 8 may be required if target collection goal has not be met)\n\nPlerixafor 0.24 mg/kg Day 4 (Days 5 through 7 may be required if target collection goal has not be met)\n\nApheresis on Day 5 (may need to be done on Days 6-8 if target collection goal has not been met)","id":"OG001","title":"Filgrastim (Neupogen) and Plerixafor"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 20 days after last apheresis (Day 25-Day 28)","title":"Comparison of the Most Commonly Reported Adverse Events (Safety) Experienced by Participants Between the Two Arms","type":"SECONDARY","unitOfMeasure":"participants"}